Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Prostate Cancer Recurrent × Clear all

Phase

Phase NA 5 Phase 3 2 Phase 2 2 Phase 4 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 1779 Breast Neoplasms 1075 Carcinoma, Non-Small-Cell Lung 1071 Leukemia, Myeloid, Acute 848 Neoplasm Metastasis 781 Melanoma 688 Lymphoma 653 Multiple Myeloma 644 Colorectal Neoplasms 643 Ovarian Neoplasms 601 Lymphoma, Non-Hodgkin 582 Pancreatic Neoplasms 581 Prostatic Neoplasms 579 Recurrence 567 Precursor Cell Lymphoblastic Leukemia-Lymphoma 512 Leukemia, Lymphocytic, Chronic, B-Cell 489 Lung Neoplasms 488 Glioblastoma 471 Leukemia 440 Lymphoma, Large B-Cell, Diffuse 383 Brain Neoplasms 379 Lymphoma, Follicular 363 Stomach Neoplasms 339 Carcinoma, Renal Cell 339 Squamous Cell Carcinoma of Head and Neck 333 Myelodysplastic Syndromes 333 Carcinoma, Hepatocellular 324 Advanced Solid Tumors 313 Glioma 307 Lymphoma, Mantle-Cell 302

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05646550 2024-05-16

ProSperACC-1

University Hospital Tuebingen

Phase 1 Recruiting

Prostate Cancer Recurrent

Data powered by HemOnc (CC BY 4.0) Colophon ⚡